1
8 2
() 1. 71
(100) 59 4 9 6 144 2 ( 10 3)
2. 101 3 23
3. 71
2
4. 101 72
5. 71 5 14
6. 5
() 1. 101 9 6 195
13 182 101 5 (122 )(58)(1 ) (1 )
2.
3
3. 101
4. 101 3 20 21
5. 101 5 11101 1 6
6. 101 4 5 8 2,490
4
() 1. 94-100
35.6%
2. (DOTS)101 6 6,890 90%
3. X 101 62,855 2,031 99 1,797
4. (MDR) 96 5 100101 6 78
5.
() 1. 101 6 2
3,081 101
5
1,062 795 74.9%15-24 296 28.8
2.
3. 4
4. 1011640,275
5. 96 101 46 101 6 7,960
6
6. 101 6
21 () 928 415 1 101 1 6 23 2,480 311 90%
() 1. 100 266 7,665
100101101630258.2 97.86 101 297 5,365 101 10 1 65 6 6 102 1 1 50-64
2. 10-15% 100 12 1 101 3 31
7
3. 101 1 1 6 30 25 / 7
4. 101 101 8 16 1,247
5. 101 3 1 101 A/H5N1 8 10 9,561
() 1. 101
101 493 5 157
8
6 111 (70.7%) 2.
WHO 555 5 ( 5 )
3. ()
4. (Enterobacteriaceae)
5. 101 59 9
()
9
1. /
2. 101 4 9 MMR Tdap-IPV
3. 101 5 PCV 4.3 102 2-5 PCV
4. 75
() 1.
100 9 16
1
10
2
3 63 50
4
2. 98 101 6 189 19 81 24 57 112 101 9 101
3.
1 9 17 24
2 13 8
11
3
15 21 28 24
() 1.
99 7 1101 79203 530
2. 101 39 1311
3. 14 101 6
12
131 1 3,322 4.
101 16 45 103 1 1
5. 101 10
() 1. 101 14
19,179 5
2. 109 104 96 1 4,131 100 3 6,628 94 71.5% 100 5%
3.
13
/100 6.51 16.54
() 1.
101 22 292 101 6 126,271 188,605 1.52 44.21%
2. 97 7 499 1,696 95%100 1,211 96.12%101 6 657 96.65%99 27 100%100 40 97.5%101 101 6 35 88.57%
14
3. 100 3,507 1015.1954,406 19.3 899 20.4% 13 2 99 11 100 12
() 1. 101
101 505 238 7 14
2. 101 193 6 5
3. /98 58
4. 1 10
15
2 3
() 1. 5 (33
2510026) 11
2. 101 1 1 103 12 31 200
16
3. 100
4.
5. () 1
24 98.7
2 () ()
6. 45
4 5 4 6 5 10
17
1 2
3 4 5 6 1
2
3 4 103 5 6 7 8
9 10
18
1 102 1 49 22 55% 10
2 101 4
3 () 100 200 101 7 9 101 9 11 101 9 1
4 100 11 1 101 6 22
5 101 7-9
19
6
7 skill mix
8 101 8 21 9 26
7. 1 101 7 10
() 101
2 2/3( 60 100 ) 101
3 1012
20
120 6 720
8. 1 101 6 46
2 95 100
2,918 ( 1,450 1,468 )
3 100 69 2,488 101 80
4 100 101 101 6 30 747 358 41 12 )9 9 911 440 4312 416
9. 1 101 7
16
21
101 8 317 10
2 102 102
() 1.
2.
1 25
2 101 7 97 6 65 (56711) 11 21 ()
22
3. 24 95 3 101 8 3,484,795
4. 15 ( 25 ) CDC 61%
5. 1 101 ()
9102 2 100 81 10,038 1,288 150
2 101 3 101 ()
11 100 3,286 1,53011,048
4 101 102 16
5 2,000 ( 1,497 227 216 3)
23
6. ( 12 100 1 101 8 64,528 )
7. () () () ()
() 1. 1
100 12 274
2 100 12 208
3 100 12 150
2. 100 12 IC 32
24
3. 101 6 189 175
() 1. 1
HIS 100 48 ( 30 18 )101 7
2 32 ( 23 9)(PACS)
3 100 19 101 1-8 4,623
4
25
2.
1 101 1 8315 3
2 101 1 8 314 241 2 40
3. 101 86 1 8 2 9,815 9,535 30,809 1 4,821 875 3 9,579 3,200
4.
5.
26
101 40 26 9 1600
6. 100 776 101 31( 27)
7. 24 101 1 8 201 94.37% 101
8.
9.
27
1 8 29
2 8 29 2 8 30 1
3 8 31 8 31 IDS 9 3
4
5 3,550
() 1. 1
2
(22 )(63 )(368 )
28
3
5 2. 1
99 100 1 130 25 2 157
99 100 4,55099 100 5,117 9667
2 ()101 8 100 101 13
3. 1
97 2.3%98 5.7%99 16.3%100 21% 101 8 22%
29
100 61,675 97 3.5 101 8 37,622 100 61%
9,443 101 CDR
2 100 100 30 101
4. 7 7 8 7 8 1 2 101 2 23 7 12 9 6 95
5.
30
1 99 35 2.98%100 ( 1 )100 11
2 ()()
3 100 4 101
31
4 101 7 102 7
5
6 98 9 101 6 94 266
() 1. 99 4 1
99 3 604 101 6 95
2. ()
32
101 6 6.93
3. 101 6 306 1.19%
4. 7 100 12 1
() 1. 1 100
4.39 4.17 5.01% 4 5,511 4 5,366
33
145 0.32% 2 101 1 5
4.42 4.14 6.33%45,95345,264 689 1.50%
3
2. 1 100 7 1 7
15 101 1 17 61611
2
3. 1 101
21.47 101 6 20
34
57114C 6 43 12.83
0.572 8.527 9% 4 2 6 3%9.099
101 1 1
2 101 3.2
3 1008RBRVS 37 100 9 100 10 24 101 6 28
35
101 9 101 12
4. (1)(2)(3) 3 101 6 384.3
() 1.
101 6 280 110
2. 1 101 6
1,927 1.15 7 17.48 1,518 1,165
2 101 101 6 1.37 3.18
36
3. 10162,019 5,692
4. 1
101 6 42.1 18
17.8 17
7.3
2 37
5. (IDS) 48 (40 )
37
101 25 4-6 (100 4.39 )
() 1.
90 99 150 () 100 () 5.7 99 100 32,468 100 12 17 166.2
2.
3. 98 12 101 193
38
46 100 0.15 12.5%
() 1. 100
1 4 100 1 26 1 2
2.
1
2
39
3 101 6
4
5 1 1
6 101 8 13 2348 ( 118 )
() 1. 101 1 6 212
18 1,102 111
2. 101 2 6 4
40
30 1,510 734 609 51 47 47 10 12 16 2 1 1.3%
3. 61 612
4. 101 7 9 102 4LC/MS/MS
5. 101 1 6 27
() 1. 1 101 8 8 11
17 1 31
41
2 101 1 6 167 )7773
2. 1 101 6
21 5,220 2 101 6
224 3
101 QSA 9 63.31%101 6 5,521 714 685 17 () 101 3 20 100 7 1 424
42
5 101 6 8,375 97.7%
3. 1
http://fadenbook.fda.gov.tw/101 8 13 435 8,628 101 4 400
2 101 6 28 101 7 9
43
4. 1 101 8 9
8 15
2 101 9 6 101 9 12 101 9 20
3 101 7 21 () () 8 2
()
44
1. (cGMP) 101 6 160 ( 10 3 ) 20 ( 151 ) GMP 40 PIC/S GMP
2. 101 6 685 97 64 3 30 98 64330 10 73 480
3. 184 4 5
4. 101 6 52
5. 101 644927
6. 6
7. 101 6 27 GMP GMP
45
8. 101 4 26 3
9. 101 5 30
10. GMP 16 GMP
11. 20 309 4 PCNB 98.71%
12. 101 8 1 10
13. Wnt 1 2
14. 101 6
46
15. 4 14 5 5 35 4 14 11 30 10
() 1.
101 6 18 4
2. (REMS)
3. 101 4 5 (REMS) 101 7 REMS 9 12 4 58
4. 4
5.
47
22 14 31 4 9
6. 71
() 1.
101 6 9,575 83 0.87%
2. 101 6 8,644 100 8,218 5.2%
() 1. 101 6
4,080 1,707.6 99 1 13.9% 101 6 4.08%
2. 99 3 99 1 3 190 216
48
43 149 21.9% 18.4 %
()
101 6 481 100 3 3 96 101 6 6 6
() 1. 101100
186 94.04% 1 98.35%101 1-5 85 96.35% 99 100 101 4 15 101 1 6 2 8,485
49
2. 101 1 6 2 7,977 768 10 6,842 1,875 4,205 1,674
3. 101 1 6 5,688 340 6,579
4. 100 158 71.4%99 67.2% 100 45.6% (93 24%97 35.1% 2025 50%) 99 11 24 100 5 11 101 6 1,659 99.8%
5.
50
28 4 1 10 50 99 1.090 100 1.079 101 1-6 1.07816 1.130 18 101 6 101 942 198 293 491 52.12%(491/942)
6. 101 6 193 78 40 101 6 3,560 20
51
101 6 36 9 4,000 101 1-6 291 5 50 100 100 11 101 6 82 244
() 1. 4 5
100 1 12 35 2,375 97.4% 98%
2. 99 100 47 101 3 15 101 1 6 5 6,694 1003417 9,898 91.38% 97%
3. 5 1 100 30 9,118 101 22 2,659 146
4. 7 7
52
99 103 1 1 98.3%100 100 80%100 1 1 98%101 1-5 46 7 84.2% 100
5. 22 1 6 14 2 4 45
6. 132 748 383 6,506 13 154
53
22,475 101
7. 100 2,954101 101 6 6,598
8. e1003973510116139,679 3,045 31 Teens 9 1,981 19 87 113 2 6,264 62 51 414 msn 217
54
() 1. 40 64 3 155
65 1101 1 6 112 (100 16)109
2. 100 3 103 6 166 14 416 582
3. 100 18 62.3% 44.6%
4. 100 20 22 7 5 3,843 2 3,958 3 6,418 90%
5. 101 Healthy Lifestyle Healthy Blood Pressure 1,014 887
55
1,987
6. 100-104101-103
7.
8. 100 536 1,400
9. 483100 174 101 186 22
10. 100 126 50 33
56
2,881 12 5,305 65
11. 100 9 65 81 101 1 6 50 69 29.8 50-69 62.3 65 269 101 1 5 2,504
12. 100 1,333 477 26%99 100 60%101 622 371 1,333 253 770 80%
57
13. 99 100 100 12 13 101 6 21101 40 101 101 4 11 20 WHO Working Group on HPH and Age-Friendly Health Care
14. WHO-100 9 20 101 20
58
APEC101 8 28-29 2012 APEC
15. 100 12 229293 424101 6 22 749 3292 101 12 5
() 1.
Alliance For Healthy Cities, AFHC 101 6
59
8 11 AFHC2 30 2 34
2. 1 101 6 76 WHO
2 100 12 Health Care Without HarmHCWHThe First Global Climate and Health Summit HCWH UNFCCC 17 17 Climate Change and Public Health: Healthy Climate, Healthy People, Healthy Economy WHO TF on HPH and Environment WHO The First Global
60
Climate and Health Summit 3 100 WHO-HPH Recognition
Project 15101 6
4 101 4 11-13 20
5 101 21 125 ()46 4039
3. 1 101 18 142
( 38.6 5
2 100 13
61
4. 94 101 28 101 6 19
5. 100 12 7,411 303
6. 1 3,699
101 6 293
2
62
101 6 46
7. 1 101 6
9,345
2 100
8. 100 100 1 1,172 70 604(39.84%)126
() 1. 22
101 60 600 22
63
101 6 3,310 30 8,000 187
2. 368
3. 0800-367-100101 -
4. 1 18 99
64
64.1% 100 65.1%
2 100 22 1035 138 101
3
5. 1
2 101 18 143
()
65
1. 100 99 19.8% 19.1% 99 9.1% 8.2%
2. 101 1 6 34 6,416 2,995 2,939 253 8,000
3. 101
4. 101 113 2012 65
5. 101 5 (DG SANCO) Ms. Paola Testori Coggi 37 1
6. 101 3 1 200
66
101 6 2,054 96%
7. 101 1 6 4 2,8282012 3 1,067
8. 98 6 4 101 1 6 96 2,551
() 1.
18 96 17.2% 100 11.3%
2. 97 174.4 100 173.7 0.4% 97 10 94.4 100 93.4 1.1% 105 10%
3. 92 96 41% 94 98 43% 2% 58% 60% 2%
4. 101
67
1 6 279 122.7 38.6 62.3 55.4 2,357 5,836 1,456 868 12,157 664 1,843
5. 101 1 1 3 1 3HPV101 3 22 6 30 1 2,034 2 2,026 1 1,354 2 1,340
6. 222 69
7. 97 100 39 8
68
101 37 8. 69 101
1 5 8,000 99 1 42% 98 39% 3%
() 1.
101 6 646 30
2. 5 1 4
3. 8 101 6 48 78 17
() 1. DBPR108
69
101 1 FDA 7
2. DBPR104 99 7 30 11 23 FDA
3. 5-MTP50%
4. 71 101 2 1 2
5. -
70
CKD2011 10 CKD
6. B 101 4
7. respiratory syncytial virus, RSV RSV
8.
71
Sun1 Sun1 2.5
9.
10.
() 1.
65 (Toward Universal Coverage)
72
WHA (2005) 1610 101 5 24 DG SANCO(WMA)(WHPA)
2. APEC(2011 2012)APEC (HWG)(Health Policy Dialogue) 2012 APEC (APEC High-Level Meeting on Health and the Economy)(A Life Course Approach to Reducing the Economic Burden of Disease)Johnson & Johnson
3. APEC
73
(Workshop on Cost-effectiveness of Strategies for Human Security) APEC 101 8
4. 2011 25 40 2012 101 11 14 16
() 1. 101
12
2. Non-communicable Disesses-Global priorities and solutions
3. (1) 101 8 7
74
(2) (TaiwanIHA)(AMDA)1008 130 130 101 2 1
(3)
4. 100 6 26
75
101 8 1
SARS
5. (1) ()
e-Health (2)
(3) 101 8 179
() 1. 100
23 146
76
101 8 8 50
2. 100 13
() 101 8 52
699
101/2/15 Mr. Bruce Atkinson 5
101/3/01 Pham Van Thuc 6
101/3/20 Mr. Melinda Pavey 5
101/4/9-10 Esperanza Martinez 2
101/4/30 Dr. Jewel Mullen 7
101/5/1 Hon. Jenniffer A. Gonzalez-Colon 6
101/7/25 Excmo. Lic. Gudy Rivera Estrada 7
101/7/27 Dr. Douglas Slater
77
Mr. Andreas Wickham 2
(101.0108)
262 50 300 61 19 6 1 52 699
() 1. 1
2 3 4 2. 1
78
2
3 4 5
() 1. 22 102
2. 3. 1 2 3 4
() 1. 1 2 3
79
2. 1 101
2 3. 1 2
2
3 4
() 1. 2. 55 64 3.
4. 5.
6.
HPV 7.
80
() 1. 2. CDC 3. 4. Gastein European Health Forum
()
()
()
81
() 96 98 100
() 1.
2.
3. 4.
() 2143
82
1670
() 1.
2. 3. 4. 5.
()
() 1.
2.
83
IDS
3. (101-105 )
4.
() 1.
2. 101
() 1. 99 4 1
2.
84
() 1.
6 ()
2. 36
() DRG
1. DRG
2.
85
()
() 102 1 1 6
() 1.
101 3 6 25 7 19
86
2.
3.
10-15 4.
()
() 1. 2. 3.
4.
100%
() 1. 71
87
2. 71
()
()
() 103-104 PCV
()
88
()
() MIT
()
89
()
1.
2.
()
()
()
()
90
1.
2. 290
3.
4. 101 6
5. 100 101 102 101 102
()
91
()
101
()
() ()
()
()
()
()
92
()
()
()
() () () () ()